Načítá se...
A normal genetic variation modulates synaptic MMP‐9 protein levels and the severity of schizophrenia symptoms
Matrix metalloproteinase 9 (MMP‐9) has recently emerged as a molecule that contributes to pathological synaptic plasticity in schizophrenia, but explanation of the underlying mechanisms has been missing. In the present study, we performed a phenotype‐based genetic association study (PGAS) in > 1,...
Uloženo v:
| Vydáno v: | EMBO Mol Med |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5538295/ https://ncbi.nlm.nih.gov/pubmed/28623238 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201707723 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|